Search

Author/Creator William, Sandborn

1. P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study. (December 2020)

Authors:
William, Sandborn; Geert, D'Haens; Doug, Wolf; Stephen, Hanauer; Igor, Jovanovic; Subrata, Ghosh; AnnKatrin, Petersen; Steven, Hua; Hwan, Lee Ji; Lorna, Charles; Keith, Usiskin; Silvio, Danese; Brian, Feagan
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1
Page Start:
S6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study. (December 2020)

Authors:
Silvio, Danese; Brian, Feagan; Stephen, Hanauer; Igor, Jovanovic; Subrata, Ghosh; AnnKatrin, Petersen; Steven, Hua; Hwan, Lee Ji; Lorna, Charles; Denesh, Chitkara; William, Sandborn; Geert, D'Haens
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1
Page Start:
S8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension. (December 2020)

Authors:
William, Sandborn; Brian, Feagan; Stephen, Hanauer; Séverine, Vermeire; Subrata, Ghosh; Wenzhong, Liu; AnnKatrin, Petersen; Lorna, Charles; Vivian, Huang; Keith, Usiskin; Doug, Wolf; Geert, D'Haens
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1
Page Start:
S8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PD-010 Histological Remission Induced by Ozanimod is Associated with Clinical Remission and Endoscopic Mucosal Healing: Results from the TOUCHSTONE Study. (February 2017)

Authors:
William, Sandborn; Brian, Feagan; Geert, D. 'Haens; Barrett, Levesque; Rish, Pai; Stephen, Hanauer; Douglas, Wolf; Severine, Vermeire; Subrata, Ghosh; Huiling, Li; Darryl, Penenberg; Paul, Frohna; Richard, Aranda; Allan, Olson
Journal:
Inflammatory bowel diseases
Issue:
Volume 23(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PD-011 Efficacy, Safety and Timing of Dose Adjustment of Subcutaneous Ustekinumab Maintenance in Moderate –Severe Crohn's Disease Patients in IM-UNITI. (February 2017)

Authors:
Bruce, Sands; Christopher, Gasink; Douglas, Jacobstein; Long-Long, Gao; Jewel, Johanns; Philippe, Szapary; Jean-Frédéric, Colombel; Stephan, Targan; Subrata, Ghosh; William, Sandborn
Journal:
Inflammatory bowel diseases
Issue:
Volume 23(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PD-012 Endoscopic Healing in the Ustekinumab Phase 3 UNITI/IMUNITI Crohn's Disease Program and Relationship of Clinical Outcomes to Baseline Ulceration Status. (February 2017)

Authors:
William, Sandborn; Christopher, Gasink; Daphne, Chan; Yinghua, Lang; Paul, Pollack; Stephen, Hanauer; Douglas, Wolf; Douglas, Jacobstein; Jewel, Johanns; Philippe, Szapary; Brian, Feagan; Paul, Rutgeerts
Journal:
Inflammatory bowel diseases
Issue:
Volume 23(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗